Commencing in 2020, all applications for Cancer Council Victoria Grants-in-Aid will apply directly to Cancer Council Victoria. Applications will open in June 2020. More information will be available over the coming months.
For researchers applying to NHMRC Ideas Grants in 2020, the application process is outlined here.
Victorian researchers remain eligible for Cancer Council NSW Project Grant scheme funding (previously Box Rallies). For information about how to apply for Cancer Council NSW Project Grant scheme funding click here.
Grants-in-Aid support research for 1 to 3 years. They're awarded based on each project's:
- relevance to cancer,
- excellence,
- the value of the research, and
- the researcher's capacity to successfully complete the research described in the application.
All applications go through a rigorous peer-review process. In 2019 Cancer Council Victoria spent $4 million on Grants-in-Aid, including funding for low survival cancers research from the Victorian Government through the Victorian Cancer Agency and ovarian cancer research from the Ovarian Cancer Research Foundation. Current recipients are listed below.
New projects commencing in 2020
Dr Holly Barker, Dr Kristy Shield-Artin, Dr Cassandra Vandenberg and Dr Gayanie Ratnayake
The Walter and Eliza Hall Institute of Medical Research
Identifying new treatment options for the rare and aggressive ovarian carcinosarcoma (2020 -2022)
Co-funded by the Ovarian Cancer Research Foundation
Dr Paul Beavis, Prof Phillip Darcy, Prof Benjamin Solomon and Prof Sherene Loi
Peter MacCallum Cancer Centre
Enhancing cell-based therapy of cancer (2020 -2022)
A/Prof Daniel Buchanan, Prof Mark Jenkins, Prof Ingrid Winship, Prof Finlay Macrae, Prof Alex Boussioutas and A/Prof Christophe Rosty
University of Melbourne
Why does colonoscopy fail to prevent cancer of the large bowel in people with Lynch syndrome? (2020 -2022)
Prof Suzanne Cory and Dr Gemma Kelly
The Walter and Eliza Hall institute of Medical Research
Testing a promising new therapeutic target (MNT) to improve treatment of diverse human lymphomas and other cancers driven by high levels of the oncoprotein MYC (2020 -2022)
Prof Paul Donnelly and A/Prof Carleen Cullinane
University of Melbourne
Diagnostic imaging and therapy of cancers with copper radiopharmaceuticals (2020 -2022)
Dr Debra Gook, A/Prof David Westerman and Prof Claus Anderson
The Royal Women’s Hospital
Purging cancer cells from ovarian tissue cryo-stored from women with leukemia for safe autotransplantation and restoration of fertility (2020 -2022)
Dr Ian Majewski and Dr Peter Valk
The Walter and Eliza Hall Institute of Medical Research
How does the DNA damage that accumulates with age influence cancer risk? (2020 -2022)
Dr Delphine Merino, Dr Melissa Davis and Dr Belinda Yeo
Olivia Newton-John Cancer Research Institute
Design new treatments for patients with aggressive breast cancer using sequencing and drug response prediction (2020 -2022)
Dr Ashley Ng, Dr Kira Behrens, Prof Warren Alexander, Dr Rebecca Feltham, Prof John Silke and Dr David Komander
The Walter and Eliza Hall Institute of Medical Research
Drugging Undruggable Targets in Ph+ B-cell Acute Lymphoblastic Leukaemia (2020 -2022)
Prof Richard Pearson
University of Melbourne
Combinatorial targeting of cellular “housekeeping” processes to treat cancer (2020 -2022)
Prof Andrew Perkins
Monash University
Towards a cure for myelofibrosis (2020 -2022)
Funded by the Victorian Government through the Victorian Cancer Agency
A/Prof Jake Shortt and Dr Lev Kats
Monash University
Determining the reasons why leukaemia and lymphoma become resistant to treatments that alter
the methylation of cancer DNA (2020 -2022)
Dr Lorey Smith and Dr Brendon Monahan
Peter MacCallum Cancer Centre
Preventing Resistance to Targeted Therapy in Melanoma (2020 -2022)
Dr Florian Wiede
Peter MacCallum Cancer Centre
Enhancing the immune system in combating liver cancer in obesity (2020 -2022)
Funded by the Victorian Government through the Victorian Cancer Agency
Projects commenced in 2019
Prof Robin Anderson, Prof Robert Parton
Olivia Newton-John Cancer Research Institute
Loss of a protein called caveolin-1 in host cells surrounding tumour results in promotion of breast cancer metastasis (2019-2021)
Dr Nicholas Clemons, Prof Wayne Phillips, Dr Gang Chen, Dr Cuong Duong, A/Prof Sarah-Jane Dawson, Prof David Watson, Prof Reginald Lord, A/Prof David Wang
The University of Melbourne
Development of a simple blood test to guide treatment decisions for patients with oesophageal cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency
Dr James Dowty, A/Prof Daniel Buchanan, Prof Ingrid Winship, A/Prof Robert Waterland, Dr Jihoon Joo, Prof Mark Jenkins, Prof Melissa Southey
The University of Melbourne
Heritable methylation marks associated with colorectal cancer risk (2019-2020)
Dr Moritz Eissmann, Prof Matthias Ernst, Prof Alex Boussioutas
La Trobe University
Testing antibodies inhibiting IL33-signalling against gastric cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency
A/Prof Thomas Gebhardt
The University of Melbourne
Long-term immune control of clinically invisible melanoma (2019-2021)
Dr Catherine Granger
The University of Melbourne
A randomised control trial to evaluate the effect of exercise and self-management on outcomes of people with operable lung cancer (2019-2021)
Funded by the Victorian Government through the Victorian Cancer Agency
Dr Lev Kats, Prof Ricky Johnstone
Peter MacCallum Cancer Centre
Development of new targeted therapies for acute myeloid leukaemia (2019-2021)
Dr Simon Keam
Peter MacCallum Cancer Centre
Understanding and avoiding radiation resistance in prostate cancer using personalised medicine (2019-2021)
Prof John Mariadason
Olivia Newton-John Cancer Research Institute
A new way to treat bowel cancer (2019-2021)
Prof Neil O'Brien-Simpson, A/Prof Andrea O'Connor, Prof Michael McCullough, Dr Jason Lenzo
The University of Melbourne
Under the tongue vaccine for oral and oesophageal cancers (2019-2021)
Dr Lorraine O'Reilly, Prof Andreas Strasser, A/Prof Nicholas Huntington
The Walter and Eliza Hall Institute of Medical Research
Combating immunotherapy toxicities to guide safer gastric cancer therapy using a new pre-clinical model (2019-2021)
A/Prof Louise Purton, A/Prof Carl Walkley, Dr Meaghan Wall, Dr Helene Jousset
St Vincent's Institute of Medical Research
Identifying better therapies for blood cell cancers (2019-2021)
Prof Andrew Scott, A/Prof Hui Gan, Prof Weisan Chen
Olivia Newton-John Cancer Research Institute
Improving GBM Response to Antibody-Drug Conjugate Therapy (2019-2020)
Prof Matthew J. Watt, Dr Renea A. Taylor, A/Prof Daniel Nomura
The University of Melbourne
Targeting fatty acid metabolism for prostate cancer therapy (2019-2021)
Projects commenced in 2018
A/Prof Phillip Darcy, Dr Paul Beavis, Prof Dale Godfrey
Peter MacCallum Cancer Centre
Investigating the role of a novel immune cell subset in cancer (2018-2020)
A/Prof Thomas John, Prof Andrew Scott, A/Prof Hui Gan
The Olivia Newton-John Cancer Research Institute
New treatments for mesothelioma (2018-2020)
Projects commenced in 2017
Dr Peter Janes, Prof Andrew Scott, A/Prof Thomas John
Monash University (2017-2018); La Trobe University (2018-2019)
Targeted antibody therapy for malignant mesothelioma
Lyall Watts Mesothelioma Research Grant (2017-2019)
Projects commenced in 2016
A/Prof Kieran Harvey, Dr Nicola Waddell, A/Prof Kaylene Simpson
Peter MacCallum Cancer Centre
What causes mesothelioma and how can we treat it?
Lyall Watts Mesothelioma Research Grant (Sept 2016 - Aug 2019)